An analysis of data breaches affecting 500 or more individuals reported to the U.S. Department of Health and Human Services ...

A capsule neural network model called AMP-CapsNet achieved 97.29 percent test accuracy in classifying antimicrobial peptides ...

A hacked hospital can delay treatment. A manipulated genome database can distort an outbreak response. Cyberbiosecurity is ...

Cardiff Oncology, Inc. announced that on October 22, 2026, Dr. Roger Sidhu, Chief Medical Officer of the company separated from the Company in connection with a mutually agreed upon transition. The ...

As agriculture continues to evolve in a world driven by technology, Dr. Haipeng Yu is helping guide innovative research at ...

How is plant breeding technology changing breeders' decisions? Gene-G's Dagan Mor explores AI, genomic data, predictive tools ...

Tempus AI, Inc. (NASDAQ: TEM) today announced that its xR assay has received certification under the European Union's In Vitro Diagnostic Regulation (IVDR) as a Class C in vitro diagnostic device. The ...

Tempus AI said in an October 26, 2026 announcement that its xR RNA-sequencing assay has received certification under the ...

CHICAGO--Tempus AI, Inc. (NASDAQ: TEM) today announced that its xR assay has received certification under the European ...

Nigerian researchers build virtual reality genomics tools to teach PCR, expand practical science training and support African health research.

Abbott’s WGS-based Oncodetect MRD test showed a 30% sensitivity improvement for post-surgical colorectal cancer recurrence.